Showing results (771-780 of 803) with videos related to

Sort By:
Pageof 81
The European Respiratory Journal|March 12, 2016
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBSimon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, et al.
Antibiotics (Basel, Switzerland)|November 27, 2021
Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis NetworkLia D'Ambrosio, Rosella Centis, Claudia C Dobler, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2019
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelinePayam Nahid, Sundari R Mase, Giovanni Battista Migliori, et al.
ERJ Open Research|December 24, 2025
A multinational Delphi consensus on tuberculosis screening of migrants in EuropeMarina Pinheiro, Ana Aguiar, David N Moreira, et al.
Scandinavian Journal of Work, Environment & Health|January 24, 2024
Respirable crystalline silica and lung cancer in community-based studies: impact of job-exposure matrix specifications on exposure-response relationshipsJohan Ohlander, Hans Kromhout, Roel Vermeulen, et al.
The European Respiratory Journal|April 15, 2016
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBSimon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 26, 2023
Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung diseaseD Visca, R Centis, E Pontali, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 24, 2022
Clinical standards for the diagnosis, treatment and prevention of TB infectionG B Migliori, S J Wu, A Matteelli, et al.
The European Respiratory Journal|August 11, 2011
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateD Falzon, E Jaramillo, H J Schünemann, et al.
Pageof 81